Pennogenin 3-O-β-Chacotrioside Attenuates Hypertrophied Lipid Accumulation by Enhancing Mitochondrial Oxidative Capacity

Seungmin Yu,Hee Min Lee,Jangho Lee,Jin-Taek Hwang,Hyo-Kyoung Choi,Yu Geon Lee

DOI: https://doi.org/10.3390/ijms25052970

IF: 5.6

2024-03-05

International Journal of Molecular Sciences

Abstract:Excessive lipid accumulation in adipocytes is a primary contributor to the development of metabolic disorders, including obesity. The consumption of bioactive compounds derived from natural sources has been recognized as being safe and effective in preventing and alleviating obesity. Therefore, we aimed to explore the antilipidemic effects of pennogenin 3-O-β-chacotrioside (P3C), a steroid glycoside, on hypertrophied 3T3-L1 adipocytes. Oil Red O and Nile red staining demonstrated a P3C-induced reduction in lipid droplet accumulation. Additionally, the increased expression of adipogenic and lipogenic factors, including PPARγ and C/EBPα, during the differentiation process was significantly decreased by P3C treatment at both the protein and mRNA levels. Furthermore, P3C treatment upregulated the expression of fatty acid oxidation-related genes such as PGC1α and CPT1a. Moreover, mitochondrial respiration and ATP generation increased following P3C treatment, as determined using the Seahorse XF analyzer. P3C treatment also increased the protein expression of mitochondrial oxidative phosphorylation in hypertrophied adipocytes. Our findings suggest that P3C could serve as a natural lipid-lowering agent, reducing lipogenesis and enhancing mitochondrial oxidative capacity. Therefore, P3C may be a promising candidate as a therapeutic agent for obesity-related diseases.

biochemistry & molecular biology,chemistry, multidisciplinary

What problem does this paper attempt to address?

### Problems the Paper Attempts to Solve

This paper primarily explores the inhibitory effects and mechanisms of **Pennogenin 3-O-β-Chacotrioside (P3C)** on excessive fat accumulation. Specifically, the study aims to address the following issues:

1. **Fat Accumulation and Obesity**:
- Excessive fat accumulation is one of the main causes of metabolic disorders such as obesity. The study investigates the effectiveness of P3C in inhibiting fat accumulation in adipocytes.

2. **Expression of Lipogenesis-Related Genes**:
- The study evaluates the impact of P3C on the expression of lipogenesis-related genes (such as PPAR γ, C/EBP α, etc.) and verifies its regulatory mechanisms at the transcriptional level.

3. **Enhancement of Mitochondrial Oxidative Function**:
- Whether P3C can improve energy metabolism in adipocytes by enhancing mitochondrial oxidative phosphorylation capacity and thereby reduce fat accumulation.

4. **Potential as a Therapeutic Agent**:
- The study explores the role of P3C as a natural compound in inhibiting lipid accumulation and improving mitochondrial function, thereby assessing its potential as a therapeutic agent for obesity-related diseases.

In summary, through experimental research, this paper reveals the mechanisms by which P3C inhibits fat accumulation and enhances mitochondrial oxidative function, providing scientific evidence for its potential as a candidate drug for the treatment of obesity-related diseases.